What do we need to know?

Some of the key questions requiring careful consideration (although they may be unanswerable) are:

- Are multiple chronic diseases the inevitable price that we must pay for our greater longevity?

- Does the level of complexity associated with most multiple chronic diseases exceed the capacity of GRIN technologies to offer tangible solutions?

- Even if we could eliminate chronic diseases through GRIN technologies in the mid to long term, will we be able to use innovations to mitigate their impact in the short term?